Paper Tigers Or Paper Bullets? FDA Curbs Repeat Warning Letters, Violations

Enforcement policies under way within FDA's Office of the Chief Counsel could eliminate the practice of issuing multiple compliance warning letters, according to agency officials

More from Archive

More from Medtech Insight